Pulse Biosciences, Inc. PLSE Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulse Biosciences, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pulse Biosciences, Inc.'s total liabilities & equity?
- Pulse Biosciences, Inc. (PLSE) reported total liabilities & equity of $81.62M in Q1 2026.
- How has Pulse Biosciences, Inc.'s total liabilities & equity changed year-over-year?
- Pulse Biosciences, Inc.'s total liabilities & equity decreased by 38.8% year-over-year, from $133.38M to $81.62M.
- What is the long-term trend for Pulse Biosciences, Inc.'s total liabilities & equity?
- Over 5 years (2020 to 2025), Pulse Biosciences, Inc.'s total liabilities & equity has grown at a 18.0% compound annual growth rate (CAGR), from $41.29M to $94.54M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.